RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors (Retracted article. See vol. 96, pg. 1570, 2017)

被引：8

作者：

Cheraghi, Mostafa ^{[1
]}

Namdari, Mehrdad ^{[1
]}

Negahdari, Babak ^{[2
]}

Eatemadi, Ali ^{[2
,3
,4
]}

机构：

[1] Lorestan Univ Med Sci, Dept Cardiol, Khorramabad 6997118544, Iran

[2] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran

[3] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Khorramabad, Iran

[4] Lorestan Univ Med Sci, Sch Med, Dept Med Biotechnol, Lorestan, Iran

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2017年 / 87卷

关键词：

Myocardial infarction; Cell therapy; Protein therapy; Biomaterials; Delivery systems; ACUTE MYOCARDIAL-INFARCTION; SELF-ASSEMBLING PEPTIDE; BONE-MARROW-CELLS; DOUBLE-BLIND; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; PROGENITOR CELLS; CLINICAL-TRIAL; HEART-FAILURE; THERAPY;

D O I：

10.1016/j.biopha.2016.12.071

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

100103 [病原生物学]; 100218 [急诊医学];

摘要：

Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors. (C) 2016 Elsevier Masson SAS. All rights reserved.

引用

页码：37 / 45

页数：9

共 82 条

[31]

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction [J].